✦ LIBER ✦

A preliminary study of protoporphyrin-IX as a potential candidate for identification of lung cancer cells using fluorescence microscopy

✍ Scribed by Dae-Sung Hyun; Hong-Tae Kim; Sang-Hoon Jheon; Seung-Il Park; Jong-Ki Kim

Book ID: 119344353
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 690 KB
Volume: 6
Category: Article
ISSN: 1572-1000
DOI: 10.1016/j.pdpdt.2009.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of Trichostatin A as a Pot

Effectiveness of Trichostatin A as a Potential Candidate for Anticancer Therapy in Non–Small-Cell Lung Cancer

✍ Nishit K. Mukhopadhyay; Ellen Weisberg; David Gilchrist; Raphael Bueno; David J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 308 KB

Detection of pleural lymph flow using in

Detection of pleural lymph flow using indocyanine green fluorescence imaging in non-small cell lung cancer surgery: a preliminary study

✍ Kazuhiro Imai, Yoshihiro Minamiya, Hajime Saito, Taku Nakagawa, Manabu Ito… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 337 KB

The xc−cystine/glutamate antiporter as a

The xc−cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine

✍ Jun Guan; Maisie Lo; Peter Dockery; Sarah Mahon; Cristina M. Karp; Arthur R. Buc 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 373 KB

ErbB4 increases the proliferation potent

ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy

✍ Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB 👁 1 views

## Abstract Clinical and experimental data suggest that ErbB‐4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbB‐4 receptor is correlated with

Low-dose radiotherapy as a chemo-potenti

Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: A prospective phase II study

✍ Mantini, Giovanna; Valentini, Vincenzo; Meduri, Bruno; Margaritora, Stefano; Bal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Randomized study on the usefulness of et

Randomized study on the usefulness of etoposide, UFT, Ubenimex as a postoperative adjuvant chemotherapy for non-small cell lung cancer

✍ Shimizu, N.; Ando, A.; Teramoto, S.; Ono, K.; Nakajima, Y.; Saeki, H.; Konishi, 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 124 KB